Contact activation in low-density lipoprotein apheresis systems

Artificial Organs

Volumn 29, Issue 1, 2005, Pages 47-52

  Krieter, Detlef H ^a   Steinke, Jörn ^b   Kerkhoff, Markus ^b   Fink, Edwin ^c   Lemke, Horst Dieter ^d   Zingler, Christine ^e   Müller, Gerhard A ^b   Schuff Werner, Peter ^e  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d Membrana Research   (Germany)

^e UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Angotensin converting enzyme inhibitor; Bradykinin; Contact activation; Hypercholesterolemia; Low density lipoprotein apheresis

Indexed keywords

CHEMICAL ACTIVATION; DIALYSIS; ENZYME INHIBITION; LIPOPROTEINS; PATIENT TREATMENT;

ANGIOTENSIN CONVERTING ENZYME INHIBITORS; ANGOTENSIN CONVERTING ENZYME INHIBITOR; BRADYKININ; CONTACT ACTIVATION; CONVERTING ENZYME; DEXTRAN SULPHATE; ENZYME INHIBITORS; HYPERCHOLESTEROLEMIA; LOW DENSITY LIPOPROTEINS; LOW-DENSITY LIPOPROTEIN APHERESIS;

SULFUR COMPOUNDS;

BRADYKININ; CELLULOSE; DEXTRAN SULFATE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HIGH MOLECULAR WEIGHT KININOGEN; LOW DENSITY LIPOPROTEIN; POLYACRYLIC ACID; PREKALLIKREIN; ACRYLIC ACID RESIN; ANTICOAGULANT AGENT; CARBOPOL 940; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMA SUBSTITUTE;

ADULT; ANALYTIC METHOD; APHERESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME DEGRADATION; EXTRACORPOREAL CIRCULATION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; KALLIKREIN KININ SYSTEM; MALE; PRIORITY JOURNAL; PROTEIN SECRETION; STATISTICAL ANALYSIS; AGED; BLOOD; GEL; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; PRECIPITATION;

ACRYLIC RESINS; ADULT; AGED; ANTICOAGULANTS; BLOOD COMPONENT REMOVAL; BRADYKININ; CELLULOSE; CHOLESTEROL, LDL; DEXTRAN SULFATE; EXTRACORPOREAL CIRCULATION; FEMALE; GELS; HEPARIN; HUMANS; KININOGEN, HIGH-MOLECULAR-WEIGHT; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; PLASMA SUBSTITUTES; PRECIPITATION; PREKALLIKREIN;

EID: 21444455028     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2004.29007.x     Document Type: Article

References (25)

1. Tielemans C, Madhoun P, Lenaers M, Schandene L, Goldman M, Vanherweghem JL. Anaphylactoid reactions during hemodialysis on AN69 membranes in patients receiving ACE inhibitors. Kidney Int 1990;38:982-4
2. Verresen L, Waer M, Vanrenterghem Y, Michielsen P. Angiotensin- converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis. Lancet 1990;336:1360-2.
3. Krieter DH, Grude M, Lemke HD, et al. Anaphylactoid reactions during hemodialysis in sheep are ACE inhibitor dose-dependent and mediated by bradykinin. Kidney Int 1998;53:1026-35.
4. Olbricht CJ, Schaumann D, Fischer D. Anaphylactoid reactions, LDL apheresis with dextran sulfate, and ACE inhibitor. Lancet 1992;340:908-9.
5. Koga N, Nagano T, Sato T, Kagasawa K. Anaphylactoid reactions and bradykinin generation in patients treated with LDL-apheresis and an ACE inhibitor. ASAIO J 1993;39:M288-91.
6. Kojima S, Ogi M, Yoshitomi Y, Kuramochi M, Ikeda J, Naganawa M, Hatakeyama H. Changes in bradykinin and prostaglandins plasma levels during dextran-sulfate low-density-lipoprotein apheresis. Int J Artif Org 1997;3:178-83.
7. Bosch T, Lennertz D, Schmidt B, et al. DALI apheresis in hyperlipidemic patients: biocompatibility, efficacy and selectivity of direct adsorption of lipoproteins from whole blood. Artif Organs 2000;24:81-90.
8. Gordon BR, Saal SD. Current status of LDL-apheresis for the therapy of severe hyperlipidemia. Curr Opin Lipidol 1996;7:381-4.
9. Koga N, Iwata Y. Pathological and angiographic regression of coronary atherosclerosis by LDL-apheresis in a patient with familial hypercholesterolemia. Atherosclerosis 1991;90:9-21.
10. Schuff-Werner P, Gohlke H, Bartmann U, Baggio G, Corti MC. The HELP-STUDY group. The HELP-LDL-apheresis multicenter study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease. Eur J Clin Invest 1994;24: 724-32.
11. Bosch T, Keller C. Clinical effects of direct adsorption of lipoprotein apheresis: beyond cholesterol reduction. Ther Apher Dial 2003;7:341-4.
12. Seidel D, Wieland H. Ein neues Verfahren zur selektiven Messung und extrakorporalen Elimination von low-density Lipoproteinen. J Clin Chem Clin Bio 1982;20:684-5.
13. Yokoyama S, Hayashi R, Satani M, Yamamoto M. Selective removal of LDL by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis 1985;5:613-22.
14. Bosch T. Low-density lipoprotein hemoperfusion using a modified polyacrylate adsorber: in vitro, ex vivo, and first clinical results. Artif Organs 1996;20:344-5.
15. Shimamoto K, Ando T, Tanaka S, Iimura O. The determination of kinin and glandular kallikrein in human biological fluids. Atemw-Lungenkrkh 1988;1(14 Suppl.):29-36.
16. Fink E, Schill W-B, Fiedler F, Krassnigg F, Geiger R, Shimamoto K. Tissue kallikrein of human seminal plasma is secreted by the prostate gland. Biol Chem H-S 1985;366:917-24.
17. De la Cadena R, Scott CF, Colman RW. Evaluation of a microassay for human plasma prekallikrein. J Lab Clin Med 1987;109:601-7.
18. Uchida Y, Katori M. Differential assay method for high molecular weight and low molecular weight kininogens. Thromb Res 1979;15:127-34.
19. Tatami R, Inoue N, Itoh H, Kishino B, Koga N, Nakashima Y. Regression of coronary atherosclerosis by combined LDL apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study. Atherosclerosis 1992;95:1-13.
20. Kojima S, Harada-Shiba M, Nomura S. Effect of nafamostat mesilate on bradykinin generation during low-density lipoprotein apheresis using dextran sulfate cellulose column. Trans Am Soc Artif Int Org 1991;37:644-8.
21. Davidson DC, Peart I, Turner S, Sangster M. Prevention with Icatibant of anaphylactoid reactions to ACE inhibitor during LDL apheresis. (letter). Lancet 1994;343:1575.
22. Bönner G. Kallikrein-kinin Systems in shock. In: Neugebauer, E, Holaday, JW, eds. Handbook of Mediators in Septic Shock. Boca Raton: CRC Press, 1993;167-92.
23. Verresen L, Fink E, Lemke HD, Vanrenterghem Y. Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes. Kidney Int 1994;45:1497-503.
24. Smith DHG, Neutel JM, Weber MA. Effects of angiotensin II on pressor responses to norepinephrine in humans (Abstract). Life Sci 1991;48:2413.
25. Griep MA, Fujikawa K, Nelsestuen GL. Possible basis for the surface selectivity of the contact activation of human blood coagulation factor XII. Biochemistry 1986;25:6688-94.